Summary
Global Pharmaceutical Fine Chemicals – Industry and Market Analysis, examines the development of the industry and outlines the issues that are shaping the industry of tomorrow. The 170 page
report explains how fine chemicals companies serve the various sub-sectors of the pharmaceutical industry and what factors will affect the industry. This unique document will give you and your
organisation the knowledge of how pharmaceutical fine chemicals are manufactured and sold, as well as deepening understanding of the crucial role that PFC producers play in the supply of
medical chemicals to the global drug industry.
The publication contains extensive profiles of leading companies including
- BASF AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation, Central and Eastern Europe, China, Cipla Limited, Clariant, Degussa AG, DSM Fine Chemicals, Eastman Fine Chemicals, Kaneka, Krka D.D, Lonza Group Ltd, Merck & Company, Inc., North China Pharmaceutical Group Corporation, Pliva D.D., Ranbaxy Laboratories Limited, Roche Group, Sankyo Company, Limited, Shijiazhuang Pharmaceutical Group Co., Ltd, Sigma-Aldrich, Takeda Chemical Industries and The Rhodia Group Ltd.
|
|
TABLE OF CONTENTS
